Search

Author/Creator Berlin, Jordan

1. 385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results. (10th December 2020)

Authors:
Berlin, Jordan; Harb, Wael; Adjei, Alex; Xing, Yan; Swiecicki, Paul; Seetharam, Mahesh; Nandagopal, Lakshminarayanan; Gopal, Ajay; Xu, Cong; Xu, Cong; Meng, Yuan; Lee, Linda; Zhao, Yonggang; Wang, Zhengyi; Shen, Joan Huaqiong
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 385 A first-in-human study of lemzoparlimab, a differentiated anti-CD47 antibody, in subjects with relapsed/refractory malignancy: initial monotherapy results. (9th November 2020)

Authors:
Berlin, Jordan; Harb, Wael; Adjei, Alex; Xing, Yan; Swiecicki, Paul; Seetharam, Mahesh; Nandagopal, Lakshminarayanan; Gopal, Ajay; Xu, Cong; Xu, Cong; Meng, Yuan; Lee, Linda; Zhao, Yonggang; Wang, Zhengyi; Shen, Joan Huaqiong
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A410
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A clinical score for neuroendocrine tumor patients under consideration for Lu-177-DOTATATE therapy. Issue 3 (March 2021)

Authors:
Das, Satya; Du, Liping; Schad, Aimee; Jain, Shikha; Jessop, Aaron; Shah, Chirayu; Eisner, David; Cardin, Dana; Ciombor, Kristen; Goff, Laura; Bradshaw, Marques; Delbeke, Dominique; Sandler, Martin; Berlin, Jordan
Journal:
Endocrine-related cancer
Issue:
Volume 28:Issue 3(2021)
Page Start:
203
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers. (6th March 2018)

Authors:
Tolcher, Anthony; Flaherty, Keith; Shapiro, Geoffrey I.; Berlin, Jordan; Witzig, Thomas; Habermann, Thomas; Bullock, Andrea; Rock, Edwin; Elekes, Agnes; Lin, Chester; Kostic, Dusan; Ohi, Naoto; Rasco, Drew; Papadopoulos, Kyriakos P.; Patnaik, Amita; Smith, Lon; Cote, Gregory M.
Journal:
Oncologist
Issue:
Volume 23:Number 6(2018)
Page Start:
658
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A Phase II, Single‐Arm, Open‐Label, Bayesian Adaptive Efficacy and Safety Study of PBI‐05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma. (2nd July 2020)

Authors:
Roth, Marc T.; Cardin, Dana Backlund; Borazanci, Erkut Hasan; Steinbach, Margaux; Picozzi, Vincent J.; Rosemury, Alexander; Wadlow, Raymond Couric; Newman, Robert A.; Berlin, Jordan
Journal:
Oncologist
Issue:
Volume 25:Number 10(2020)
Page Start:
e1446
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours – A systematic review and meta-analysis. (March 2023)

Authors:
Das, Satya; Phillips, Sharon; Lee, Cody L.; Agarwal, Rajiv; Bergsland, Emily; Strosberg, Jonathan; Chan, Jennifer A.; LaFerriere, Heather; Ramirez, Robert A.; Berlin, Jordan; Dasari, Arvind
Journal:
European journal of cancer
Issue:
Volume 182(2023)
Page Start:
43
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Immune‐Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration‐Approved Indications for Immunotherapy. (14th January 2020)

Authors:
Das, Satya; Ciombor, Kristen K.; Haraldsdottir, Sigurdis; Pumpalova, Yoanna; Sahin, Ibrahim H.; Pineda, G.; Shyr, Yu; Lin, E.P.; Hsu, Chih‐Yuan; Chu, Shih‐Kai; Goff, Laura W.; Cardin, Dana B.; Bilen, Mehmet A.; Fisher, George A.; Wu, Christina; Berlin, Jordan
Journal:
Oncologist
Issue:
Volume 25:Number 8(2020)
Page Start:
669
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer. (22nd March 2021)

Authors:
Sahin, Ibrahim Halil; Goyal, Subir; Pumpalova, Yoanna; Sonbol, Mohamad B.; Das, Satya; Haraldsdottir, Sigurdis; Ahn, Daniel; Ciombor, Kristen K.; Chen, Zhengjia; Draper, Amber; Berlin, Jordan; Bekaii-Saab, Tanios; Lesinski, Gregory B.; El-Rayes, Bassel F.; Wu, Christina
Journal:
Oncologist
Issue:
Volume 26:Number 8(2021)
Page Start:
668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR‐Deficient Colorectal Cancer. (22nd March 2021)

Authors:
Sahin, Ibrahim Halil; Goyal, Subir; Pumpalova, Yoanna; Sonbol, Mohamad B.; Das, Satya; Haraldsdottir, Sigurdis; Ahn, Daniel; Ciombor, Kristen K.; Chen, Zhengjia; Draper, Amber; Berlin, Jordan; Bekaii‐Saab, Tanios; Lesinski, Gregory B.; El‐Rayes, Bassel F.; Wu, Christina
Journal:
Oncologist
Issue:
Volume 26:Number 8(2021)
Page Start:
668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗